Health
Rheumatoid arthritis drug improves outcomes in severely ill COVID-19 patients, finds new trial – News-Medical.Net
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial…
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial conducted in hospitals across India — one of the world’s most ethnically diverse countries. Researchers from the University of Bristol and Medanta Institute of Education and Research in India who led the study, published in The Lancet Respiratory Medicine, say it adds to existing evidence supporting the drug’s use in critically ill patients.
…
-
General20 hours agoRestaurants on the brink as business failures plateau
-
General18 hours agoQueensland government expands youth justice laws, David Crisafulli tells UN critics ‘you don’t control me’
-
General20 hours agoRegional house price growth outstrips capital cities
-
General17 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore